Cargando…

Accessibility to Oral Antiviral Therapy for Patients with Chronic Hepatitis C in the United States

Background: Hepatitis C (HCV) direct acting antiviral agents (DAAs) are safe, effective, and tolerable. Most contraindications to interferon-based treatment are no long applicable. The aims of this study were to understand the predictors of approval to drug accessibility. Methods: We studied all con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saab, Sammy, Jimenez, Melissa, Fong, Tiffany, Wu, Crystal, Bau, Sherona, Jamal, Zoha, Grotts, Jonathan, Elashoff, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913077/ https://www.ncbi.nlm.nih.gov/pubmed/27350937 http://dx.doi.org/10.14218/JCTH.2016.00011

Ejemplares similares

Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use
por: Saab, Sammy, et al.
Publicado: (2016)

Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals
por: Nguyen, Kelvin, et al.
Publicado: (2017)

Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C
por: Saab, Sammy, et al.
Publicado: (2017)

Diminishing Use of Liver Biopsy among Liver Transplant Recipients for Hepatitis C
por: Aby, Elizabeth, et al.
Publicado: (2017)

Management of Hepatitis C Antiviral Therapy Adverse Effects
por: Sung, Hubert, et al.
Publicado: (2010)

Routine Laboratory Blood Tests May Diagnose Significant Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C: A 10 Year Experience
por: Sheen, Victoria, et al.
Publicado: (2016)

Elimination of Hepatitis C in Liver Transplant Recipients
por: Saab, Sammy, et al.
Publicado: (2018)

Evaluation of the impact of rehospitalization in the management of hepatic encephalopathy
por: Saab, Sammy
Publicado: (2015)

Depression in Nonclassical Hypogonadism in Young Men
por: Korenman, Stanley G, et al.
Publicado: (2018)

Clinical Food Addiction Is Not Associated with Development of Metabolic Complications in Liver Transplant Recipients
por: Saab, Sammy, et al.
Publicado: (2017)

Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care
por: Younossi, Zobair M., et al.
Publicado: (2016)

Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions
por: Suraweera, Duminda, et al.
Publicado: (2016)

Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door
por: Frenette, Catherine T., et al.
Publicado: (2021)

Evaluation of the Cost-Effectiveness of Entecavir Versus Lamivudine in Hepatitis BeAg-Positive Chronic Hepatitis B Patients
por: Yuan, Yong, et al.
Publicado: (2008)

Impact of All‐Oral Direct‐Acting Antivirals on Clinical and Economic Outcomes in Patients With Chronic Hepatitis C in the United States
por: Park, Haesuk, et al.
Publicado: (2019)

Spotlight on grazoprevir–elbasvir once-daily combination and its potential in the treatment of hepatitis C
por: Suraweera, Duminda, et al.
Publicado: (2016)

Limited Knowledge of Acetaminophen in Patients with Liver Disease
por: Saab, Sammy, et al.
Publicado: (2016)

Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017–2019
por: Reau, Nancy, et al.
Publicado: (2021)

The Impact of Renal Function on Hepatic Encephalopathy Following TIPS Placement for Refractory Ascites
por: Zhao, Matthew, et al.
Publicado: (2023)

Access to antiviral therapy for chronic hepatitis B during COVID-19
por: Bertolli¹, Marilia Rocha, et al.
Publicado: (2022)

Risk of Cardiovascular Events in Patients with Primary Biliary Cholangitis - Systematic Review
por: Suraweera, Duminda, et al.
Publicado: (2018)

Factors associated with retention in Option B+ in Malawi: a case control study
por: Hoffman, Risa M, et al.
Publicado: (2017)

Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States
por: Stepanova, Maria, et al.
Publicado: (2017)

Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States
por: Rosenthal, Elana S., et al.
Publicado: (2016)

Oral Antiviral Therapy Utilization Among Adults with Recent COVID-19 in the United States
por: Benchimol-Elkaim, Brandon, et al.
Publicado: (2023)

Adverse effects of oral antiviral therapy in chronic hepatitis B
por: Kayaaslan, Bircan, et al.
Publicado: (2017)

Beyond unequal access: Acculturation, race, and resistance to pharmaceuticalization in the United States()
por: Adams, Crystal, et al.
Publicado: (2018)

Hepatitis C Screening: Barriers to Linkage to Care
por: Saab, Sammy, et al.
Publicado: (2019)

Patterns of Hepatitis C-Related Inpatient Mortality in the United States in the Era of Direct-Acting Antivirals
por: Alzahrani, Mohammad S., et al.
Publicado: (2020)

Cytokine Profiles Associated With Angiotensin II Type 1 Receptor Antibodies
por: Pearl, Meghan H., et al.
Publicado: (2018)

Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B
por: Xu, Kerui, et al.
Publicado: (2018)

Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
por: Antoniou, Tony, et al.
Publicado: (2023)

History of Hepatic Encephalopathy Is Not a Contraindication to Transjugular Intrahepatic Portosystemic Shunt Placement for Refractory Ascites
por: Saab, Sammy, et al.
Publicado: (2021)

The Current Management of Hepatorenal Syndrome–Acute Kidney Injury in the United States and the Potential of Terlipressin
por: Flamm, Steven L., et al.
Publicado: (2021)

Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: A Systematic Review of the Literature
por: Chow, Kenneth W., et al.
Publicado: (2022)

Tu1257: AUTOIMMUNE HEPATITIS FOLLOWING COVID-19 VACCINATION: A SYSTEMATIC REVIEW OF THE LITERATURE
por: Chow, Kenneth W., et al.
Publicado: (2022)

Correction: Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
por: Antoniou, Tony, et al.
Publicado: (2023)

Hepatitis C, mental health and equity of access to antiviral therapy: a systematic narrative review
por: Hepworth, Julie, et al.
Publicado: (2013)

Expanding Treatment Access for Chronic Hepatitis C with Task-shifting in the Era of Direct-acting Antivirals
por: Yoo, Eric R., et al.
Publicado: (2017)

Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance
por: Douglas, Mark W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cvhir3brkr6fmt5tbbmtftadbj